CommScope Technologies LLC et al. v. Belden Canada ULC et al.

IPR2024-01228

CommScope Technologies LLC filed an IPR petition challenging 49 claims related to modular cassette systems used in fiber optics. The petitioner argues that the challenged claims are anticipated or rendered obvious by prior art combinations involving Fukui, Sedor, and Sauter.

Jurisdiction
US PTAB
Case Number
IPR2024-01228
Decision Date
26 July 2024
Filing Date
26 July 2024

Detailed Summary

This Petition challenges the validity of Belden Canada ULC's patent (11656422) on grounds of anticipation (§ 102) and obviousness (§ 103). The petitioner presents multiple lines of attack, including claims anticipated by Fukui alone, or rendered obvious through combinations such as Sauter combined with Fukui, or Sedor combined with Sauter. Central to the dispute are claim construction issues regarding 'two, three, four, and six standard width units' and whether components must be 'directly adjacent.'

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in CommScope Technologies LLC et al. vs Belden Canada ULC et al. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2025-01566

Accelight Technologies, Inc. et al.vsApplied Optoelectronics, Inc.

Accelight Technologies has filed an IPR petition seeking to invalidate claims 1‑4 of Applied Optoelectronics’ ’301 patent, arguing they are obvious over three prior‑art publications. The petition focuses on the device’s carrier structure and the angled AWG surface.

patentIPR2024-01157

Imperative Care, Inc.vsINARI MEDICAL, INC.

The PTAB instituted an IPR on Inari Medical’s 11,697,012 B2 hemostasis valve patent after finding Imperative Care likely to prevail on at least one claim, based on anticipation and obviousness arguments over Schaffer, Hartley, Eller, and Garrison references.

patentIPR2025-01435

Tempus AI, Inc.vsGuardant Health Inc.

Guardant Health’s ’699 patent on duplex consensus sequencing is challenged by Tempus AI, which alleges the claims are obvious over earlier academic publications. The petition seeks institution of an IPR and cancellation of claims 1‑27.

patentIPR2025-00207

Arm Ltd et al.vsDAEDALUS PRIME LLC

Arm Ltd filed a Request for Director Review to overturn a discretionary denial that blocked an IPR on its multicore processor patent (U.S. 8,984,228). The petition cites the settlement of related litigation and prior Board findings that identical claims were invalid over the Sinharoy reference.

patentPGR2025-00071

Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.

The PTAB held that Samsung and its co‑petitioners proved all 15 claims of Netlist’s ’417 memory‑module patent obvious over the Perego disclosure and the JEDEC DDR2 standard, rendering the claims unpatentable.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call